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Direct oral anticoagulants (DOACs) uptake for stroke prevention in atrial fibrillation has been slow.
[1]
 
This study aimed to profile the prescribing of DOACs over three years to identify factors associated 
with DOAC prescribing in a Clinical Commissioning Group (CCG) without restrictions to DOACs 
use. The objectives were to identify: 
 Characteristics of patients prescribed oral anticoagulant (OAC) in a sample of general 
practices; 
 Who initiated the prescribing of OAC; 
 Recorded reasons for prescribing a DOAC rather than warfarin; 
 
This retrospective longitudinal study of OAC prescribing in adults used anonymous data submitted 
from nine general practices in Bradford, England. Ethical approval was granted by the University of 
Bradford. Practice pharmacists extracted anonymised data from the TPP-SystemOne clinical software 
by running pre-defined searches to identify new OAC prescriptions. Data was descriptively analysed 
with Excel and SPSS. 
 
The results are summarised in the Table 1. The proportion of DOAC prescribing significantly 
increased over time (x
2
(2)=63.538, p<0.01). There were no statistically significant differences 
between age, gender and type of OAC and who initiated the OAC. However, the majority of DOACs 
were initiated in the community showing general practitioners’ increasing confidence in DOAC 
prescribing. Documentation of reasons for choosing a particular OAC was poor and almost non-
existent for warfarin. Patient choice was increasingly stated as a reason to prescribe a DOAC 
indicating greater patient involvement in a shared decision-making.   
 
One third of patients were switched from aspirin to an OAC over time and they were statistically more 
likely to be initiated on warfarin than a DOAC (x
2
(1)=13.923, p<0.01). This observation was 
significant only in the community initiated prescribing (x
2
(1)=12.693, p<0.01). The effect decreased 
over time. Changing between OAC over the study period was more common for patients prescribed 
warfarin (29%) than a DOAC (4%). The main reason for switching from warfarin was inadequate 
control of time in the therapeutic range.   
 
Results of this study will be used to inform a larger study on the organisational barriers to DOACs 
prescribing. The main limitation was inclusion of surgeries with practice pharmacists only. This work 
was made possible with unrestricted educational grant from Bayer Pharmaceuticals. 
 
 
 
  
1/4/2012-31/3/2013 
(n=140) 
1/4/2013-31/3/2014 
(n=138) 
1/4/2014-31/3/2015 
(n=146) 
  
Warfarin 
(n=120) 
DOACs 
(n=20) 
Warfarin 
(n=84) 
DOACs 
(n=54) 
Warfarin 
(n=58) 
DOACs 
(n=88) 
Age (years), mean (SD) 76 (11) 77 (10) 76 (10) 76 (10) 76 (10) 76 (10) 
    <66 (number of cases) 18 2 12 7 15 9 
   66-75 (number of cases) 27 6 26 15 18 20 
   >75 (number of cases) 75 12 46 32 25 59 
Sex, male   56%  65% 56% 59% 45% 45%  
OAC split  86% 14% 61% 39% 40% 60% 
Initiator 
      
   Community  77% 80% 66% 74% 66% 83% 
   Hospital  21% 15% 32% 26% 34% 17% 
   Not stated  2% 5% 2% 0% 0% 0% 
Started as 1st line  85% 9% 60% 23% 38% 40% 
Reason for choosing as 1st line: 
      
 Patient choice  1% 18% 1% 44% 2% 46% 
 Not stated  99% 73% 99% 56% 98% 45% 
 Other* N/A 9% N/A 0% N/A 9% 
Switching (number of cases)             
  Aspirin to warfarin or DOAC 59 9 33 16 17 17 
  Warfarin to DOAC N/A 8 N/A 27 N/A 40 
  DOAC to warfarin  0 N/A 5 N/A 2 N/A 
Table 1. Summary of the baseline characteristic of patients newly prescribed OAC in Bradford, from 1/4/2012 to 31/3/2015. 
*Other: can’t attend warfarin clinic, needle-stick phobia, or drug interaction with warfarin. 
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